Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2011; 17(16): 2120-2125
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2120
Published online Apr 28, 2011. doi: 10.3748/wjg.v17.i16.2120
Variable | 6-wk mortality (n = 49, 38.3%) | 6-wk survival (n = 79, 61.7%) | P-value |
Sex (male/female) | 40 (81.6)/9 (18.8) | 67 (84.8)/12 (17.6) | 0.637 |
Age (yr) | 53.3 ± 13.3 | 53.7 ± 14.3 | 0.866 |
Etiology | 0.683 | ||
Virus | 23 (46.9) | 38 (48.1) | |
Alcohol | 11 (22.4) | 20 (25.3) | |
Virus + alcohol | 13 (26.5) | 15 (19.0) | |
Others | 2 (4.1) | 6 (7.6) | |
HCC | 0.291 | ||
No or small | 29 (59.2) | 54 (68.4) | |
Advanced | 20 (40.8) | 25 (31.6) | |
PVT | 0.786 | ||
Main trunk | 12 (24.5) | 18 (22.8) | |
Branch | 5 (10.2) | 9 (11.4) | |
Duration between rebleeding and index EVL | 12.8 ± 9.0 | 14.7 ± 11.7 | 0.528 |
1-5 d | 13 (26.5) | 20 (25.3) | 0.879 |
6-42 d | 36 (73.5) | 59 (74.7) | |
Rebleeding laboratory findings | |||
CTP score | 11.9 ± 1.9 | 8.9 ± 2.3 | 0.000 |
CTP classification | |||
A | 1 (2.0) | 13 (16.5) | 0.017 |
B | 3 (6.1) | 33 (41.8) | 0.000 |
C | 45 (91.8) | 33 (41.8) | 0.000 |
MELD score | 28.9 ± 9.0 | 16.8 ± 7.0 | 0.000 |
HE (grade) | 1.3 ± 1.5 | 0.3 ± 0.8 | 0.000 |
Cr (μmol/L) | 203.3 ± 159.1 | 114.9 ± 97.2 | 0.000 |
Na (mmol/L) | 138.7 ± 9.6 | 134.6 ± 14.3 | 0.084 |
K (mmol/L) | 4.2 ± 1.0 | 3.9 ± 0.9 | 0.171 |
Bil (μmol/L) | 263.3 ± 236.0 | 90.6 ± 135.1 | 0.000 |
Alb (g/L) | 25 ± 5 | 29 ± 6 | 0.000 |
Hb (g/L) | 83 ± 18 | 90 ± 17 | 0.041 |
WBC (109/L) | 12.5 ± 6.4 | 8.2 ± 4.7 | 0.000 |
Platelets (109/L) | 102.4 ± 69.2 | 101.0 ± 72.3 | 0.915 |
INR (PT) | 2.2 ± 0.9 | 1.5 (0.4) | 0.000 |
Rebleeding 5-d failure | 18 (36.7) | 6 (7.6) | 0.000 |
Died within 5 d | 10 | 0 | 0.000 |
Recurrent bleeding within 5 d | 8 | 6 | 0.150 |
Hypovolemic shock | 21 (42.9) | 3 (3.8) | 0.000 |
Rebleeding focus | 0.500 | ||
EV bleeding | 28 (57.1) | 47 (59.5) | |
Post-EVL ulcer bleeding | 9 (18.4) | 15 (19.0) | |
GV bleeding | 3 (6.1) | 4 (5.1) | |
Peptic ulcer bleeding | 6 (12.2) | 5 (6.3) | |
PHG | 3 (6.1) | 8 (10.1) | |
Rebleeding EGD finding | 0.019 | ||
Active bleeding | 20 (40.8) | 30 (38.0) | |
Blood in lumen | 25 (51.0) | 27 (34.2) | |
Clean | 4 (8.2) | 22 (27.8) | |
EGD Tx | 0716 | ||
Endoscopic therapy + medical | 36 (73.5) | 56 (70.9) | |
Medical therapy only | 13 (26.5) | 22 (27.8) | |
Surgery | 0 (0.0) | 1 (1.3) | |
Rebleeding infection | 42 (85.7) | 36 (45.6) | 0.000 |
Rebleeding antibiotic use | 35 (71.4) | 46 (58.2) | 0.132 |
Rebleeding Inderal use | 8 (16.3) | 37 (46.8) | 0.000 |
- Citation: Chen WT, Lin CY, Sheen IS, Huang CW, Lin TN, Lin CJ, Jeng WJ, Huang CH, Ho YP, Chiu CT. MELD score can predict early mortality in patients with rebleeding after band ligation for variceal bleeding. World J Gastroenterol 2011; 17(16): 2120-2125
- URL: https://www.wjgnet.com/1007-9327/full/v17/i16/2120.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i16.2120